DIVA Laboratories Ltd (4153) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.04x

DIVA Laboratories Ltd (4153) has a Cash Flow Reinvestment Rate of 0.04x as of December 2025, reinvesting NT$241.00K (capex NT$241.00K ) from operating cash flow of NT$5.57 Million. Check how high is DIVA Laboratories Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.04x
(Capex + Investments) / Operating CF

Total Reinvested

NT$241.00K
Capex + Investments

Operating Cash Flow

NT$5.57 Million
TWD

Capital Expenditures

NT$241.00K
TWD

DIVA Laboratories Ltd Cash Flow Reinvestment Rate (2017–2025)

Historical reinvestment intensity for DIVA Laboratories Ltd across 7 annual periods. Explore debt repayment capacity of DIVA Laboratories Ltd to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for DIVA Laboratories Ltd (2017–2025)

Year-by-year capital reinvestment analysis for DIVA Laboratories Ltd. For live market cap and broader valuation context, see how much is DIVA Laboratories Ltd worth.

Year Reinvestment Rate Total Reinvested (TWD) Operating CF Capex YoY Change
2025 0.05x NT$1.00 Million NT$20.77 Million NT$1.00 Million ▲ +178.2%
2024 0.02x NT$2.13 Million NT$123.14 Million NT$2.13 Million ▼ -43.1%
2023 0.03x NT$7.69 Million NT$252.91 Million NT$7.69 Million ▼ -86.5%
2022 0.22x NT$16.46 Million NT$73.19 Million NT$11.42 Million ▼ -83.4%
2019 1.35x NT$71.34 Million NT$52.66 Million NT$12.79 Million ▲ +403.6%
2018 0.27x NT$23.14 Million NT$86.02 Million NT$21.71 Million ▼ -81.8%
2017 1.48x NT$61.14 Million NT$41.45 Million NT$13.31 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow